Fig. 1From: Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care onlyExcerpt of health economic model structure showing care pathways in real world practice in Germany starting with patients presenting to a primary care doctor (GP) with a potential acute throat infection (ATI)Back to article page